Athlete’s foot drug may be MS therapy
Animal research has shown that common topical drugs used to treat eczema and athlete’s foot can encourage regrowth of myelin coating in damaged nerves, which may slow or stop disease progression in multiple sclerosis patients. Clinical trials have yet to begin, but research on human cells in vitro has been promising, and researchers at Case Western Reserve […]